Orasis Pharmaceuticals
Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.
Orasis Pharmaceuticals is a company in clinical trials, health care, medical, pharmaceutical based in Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA), founded in 2015.
As a business in clinical trials, health care, medical, pharmaceutical, Orasis Pharmaceuticals is listed here with the public details available about it.
Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA) is where the company is located.
Directory data places it at the Series_C stage.
Its team size is recorded as c_00011_00050 employees.
It has disclosed roughly $43M in funding.
| Sector | Clinical Trials, Health Care, Medical, Pharmaceutical |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA) |
| Founded | 2015 |
| Employees | c_00011_00050 |
| Stage | series_c |
| Total funding | $43,000,000 |
Website: www.orasis-pharma.com
Browse related
Create a free account